1. Cancer statistics, 2020;Siegel;CA Cancer J Clin,2020
2. Radiographic surveillance of patients with non-BRCA1/2 pathogenic variants;Hudson;Ann Surg Oncol,2020
3. NCCN guidelines index table of contents genetic/familial high-risk assessment: breast, ovarian, and pancreatic discussion;Daly;Risk Assess,2021
4. Genetic/familial high-risk Assessment: breast, ovarian, and pancreatic, version 2.2021, NCCN clinical practice guidelines in oncology;Daly;J Natl Compr Canc Netw,2021
5. Adherence to recommended risk management among unaffected women with a BRCA mutation;Buchanan;J Genet Couns,2017